Characterization of progesterone receptor A and B expression in human breast cancer.

The human progesterone receptor (PR) is a ligand-activated nuclear transcription factor that mediates progesterone action in target tissues. Two PR proteins, PR-A (M(r) 81,000-83,000) and PR-B (M(r) 116,000-120,000), have been described and different physiological activities ascribed to each on the basis of in vitro studies, suggesting that their ratio of expression may control progesterone responsiveness in target cells. Presence of PR in breast tumors is an important indicator of likely responsiveness to endocrine agents. However, the relative expression of PR-A and B in breast cancer has not been described, and its clinical significance has not been addressed. Expression of PR-A and B was measured by immunoblot analysis of 202 PR-positive human breast tumor cytosols. The ratio of expression of the two PR proteins (PR-A/B) ranged from 0.04 to 179.3. The median PR-A/B ratio was 1.26, and 61.4% of samples had PR-A/B ratios between 0 and 2. PR-A/B ratios deviated significantly from a normal log distribution; tumors containing a PR-A/B ratio greater than 4 were overrepresented in the group. Linear regression analysis revealed that high PR-A/B ratios, in general, derived from a low concentration of PR-B rather than high expression of PR-A. PR-A/B protein ratios were not correlated with the age of the patient or with total PR concentration. A third PR protein band (PR78kDa) was detected in a number of samples and comprised greater than 20% of total PR protein in 52 (25.7%) of the 202 tumor samples examined. The range or frequency distribution of PR-A/B ratios in samples containing PR78kDa was not different to the overall group. In summary, in PR-positive breast tumors, the ratio of expression of PR-A and B proteins is close to unity, as is seen in a number of other progestin target tissues. However, a significant proportion of tumors expressed very low levels of PR-B and a consequently high PR-A/B ratio. Although the clinical consequence of this observation is not known, the in vitro findings that PR-A may act as a repressor of PR-B suggest that tumors containing primarily PR-A may identify a subset of patients with low or aberrant response to endocrine agents.

[1]  B. Katzenellenbogen,et al.  Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors , 1995, Molecular and cellular biology.

[2]  D. Tindall,et al.  The mouse androgen receptor gene contains a second functional promoter which is regulated by dihydrotestosterone. , 1994, Biochemistry.

[3]  D. McDonnell,et al.  The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells , 1994, Molecular and cellular biology.

[4]  K. Horwitz,et al.  A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. , 1994, Molecular endocrinology.

[5]  D. Chalbos,et al.  Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. , 1994, The Journal of biological chemistry.

[6]  D. McDonnell,et al.  RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. , 1994, The Journal of biological chemistry.

[7]  E. Vegeto,et al.  The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional acitivity , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  C. Wilson,et al.  A and B forms of the androgen receptor are present in human genital skin fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Milgrom,et al.  Structure of the human progesterone receptor gene. , 1993, Biochimica et biophysica acta.

[10]  B. O’Malley,et al.  Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. , 1993, Molecular endocrinology.

[11]  K. Horwitz,et al.  Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. , 1993, Molecular endocrinology.

[12]  B. Katzenellenbogen,et al.  Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. , 1993, Endocrinology.

[13]  W. McGuire,et al.  Estrogen receptor mutations in breast cancer , 1993, Journal of cellular biochemistry.

[14]  H. Gronemeyer,et al.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.

[15]  Paolo Sassone-Corsi,et al.  More is better: Activators and repressors from the same gene , 1992, Cell.

[16]  W. McGuire,et al.  Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.

[17]  J. Graham,et al.  Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D. , 1991, The Journal of biological chemistry.

[18]  K. Calame,et al.  A dominant negative form of transcription activator mTFE3 created by differential splicing. , 1991, Science.

[19]  C. Ramachandran,et al.  Murine progesterone receptor exists predominantly as the 83-kilodalton ‘A’ form , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  K. Horwitz,et al.  5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages. , 1990, Molecular endocrinology.

[21]  J. Graham,et al.  Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. , 1990, The Journal of biological chemistry.

[22]  C. Clarke,et al.  Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.

[23]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[24]  P. Kastner,et al.  Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. , 1989, Journal of steroid biochemistry.

[25]  J. Shine,et al.  Progestin Inhibition of Progesterone Receptor Gene Expression in Human these steroids is determined in part by the cellular Breast Cancer Cells , 1989 .

[26]  K. Horwitz,et al.  Synthesis of human progesterone receptors in T47D cells. Nascent A- and B-receptors are active without a phosphorylation-dependent post-translational maturation step. , 1989, The Journal of biological chemistry.

[27]  P. Larsen,et al.  Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing , 1989, Nature.

[28]  K. Horwitz,et al.  Human progesterone receptor transformation and nuclear down-regulation are independent of phosphorylation. , 1988, Molecular endocrinology.

[29]  C. Clarke,et al.  Progestin-mediated changes in progesterone receptor forms in the normal human endometrium. , 1988, Endocrinology.

[30]  P. Chambon,et al.  The N-terminal region of the chicken progesterone receptor specifies target gene activation , 1988, Nature.

[31]  B. Katzenellenbogen,et al.  Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. , 1988, Molecular endocrinology.

[32]  B. Katzenellenbogen,et al.  Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. , 1988, Endocrinology.

[33]  J. V. Miller,et al.  Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. , 1987, Endocrinology.

[34]  M. Walters,et al.  Rat uterine progesterone receptor analyzed by [3H]R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar. , 1987, Endocrinology.

[35]  E. Milgrom,et al.  The rabbit progesterone receptor. Evidence for a single steroid-binding subunit and characterization of receptor mRNA. , 1984, The Journal of biological chemistry.

[36]  K. Horwitz,et al.  The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling. , 1983, Endocrinology.

[37]  T. Spelsberg,et al.  Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. , 1982, Endocrinology.

[38]  T. Spelsberg,et al.  Seasonal changes in the molecular species and nuclear binding of the chick oviduct progesterone receptor. , 1979, Biochemistry.

[39]  M. Radu,et al.  Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.

[40]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. , 1978, The Journal of biological chemistry.

[41]  B. O’Malley,et al.  Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. , 1972, The Journal of biological chemistry.

[42]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[43]  H. Gronemeyer,et al.  Transcription activation by estrogen and progesterone receptors. , 1991, Annual review of genetics.

[44]  E. Milgrom,et al.  Molecular action of progesterone. , 1990, The International journal of biochemistry.

[45]  J. Shine,et al.  Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. , 1989, Molecular endocrinology.

[46]  K. Horwitz,et al.  Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. , 1988, Molecular endocrinology.

[47]  K. Horwitz,et al.  Progestin action and progesterone receptor structure in human breast cancer: a review. , 1985, Recent progress in hormone research.